Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Our pricing system is unavailable. You are viewing list price.
Please call 1-800-766-7000 to place your order or try our site again later.

R&D Systems™ Recombinant Human Megalin/LRP-2 (C4) Protein CF

R&D Systems™ Recombinant Human Megalin/LRP-2 (C4) Protein CF is a large type I transmembrane cell surface protein.

Manufacturer:  R&D Systems™ 9579LR020

Catalog No. 95-79L-R020


This item is not returnable. View return policy

Description

Description

The Recombinant Human Megalin/LRP-2 (C4) Protein is derived from NS0.
Specifications

Specifications

P98164
Lyophilized from a 0.2μm filtered solution in PBS.
52 kDa
>80%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.
NS0
<0.10 EU per 1μg of the protein by the LAL method.
Human
Bioactivity not tested
4036
calcium sensor protein, DBS, DBSlow-density lipoprotein receptor-related protein 2, EC 1.1.2.3, EC 3.4.21.9, Glycoprotein 330, GP330, Heymann nephritis antigen homolog, low density lipoprotein receptor-related protein 2, LRP2, LRP-2, megalin
20μg
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
Unconjugated
Reconstitute at 250μg/mL in PBS.
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit